Methods and Compositions Related to RNA-targeted Rho Small GTPase RND3/RhoE Therapy
Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- THE TEXAS A&M UNIVERSITY SYSTEM, College Station, Texas has been assigned a patent (No. US 12129470 B2, initially filed Feb. 9, 2021) developed by Jiang Chang, College Station, Texas, and Weijia Luo, College Station, Texas, for "Methods and compositions related to RNA-targeted Rho small GTPase RND3/RhoE therapy." . . .